PureTech News

Press releases
Press Releases - 2021-12-07
Seaport
PureTech Advances Wholly-Owned Candidate LYT-300 (Oral Allopregnanolone) into Clinical Study for Potential Treatment of Neurological and Neuropsychological Conditions
Continue
Press Releases - 2021-11-16
Internal Program - LYT-100
PureTech Announces Publication of Phase 1 Results for LYT-100 in the Journal Clinical Pharmacology in Drug Development and Provides Timing Updates
Continue
Press Releases - 2021-11-15
Other
PureTech Announces Participation in Two Upcoming Investor Conferences
Continue
Press Releases - 2021-11-12
Gallop Oncology – LYT-200
PureTech Presents Clinical Trial Design Supporting Wholly Owned Immuno-Oncology Candidate LYT-200 at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Continue
Press Releases - 2021-11-11
Gallop Oncology – LYT-200
PureTech Receives Orphan Drug Designation for Wholly Owned Candidate LYT-200 for the Treatment of Pancreatic Cancer
Continue
Press Releases - 2021-11-10
Other
Karuna
PureTech Receives Approximately $100 Million from Sale of a Portion of Founded Entity Shares
Continue
Press Releases - 2021-11-09
Karuna
PureTech Founded Entity Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China
Continue
Press Releases - 2021-11-09
Other
PureTech Announces Participation at the Jefferies London Healthcare Conference
Continue
Press Releases - 2021-10-14
Vedanta
PureTech Founded Entity Vedanta Biosciences Appoints Simona Levi as Chief Legal Officer and Corporate Secretary
Continue
Press Releases - 2021-10-05
Vedanta
PureTech Founded Entity Vedanta Announces Positive Topline Phase 2 Data for VE303 in High-Risk C. difficile Infection and Exercise of $23.8 Million Option by BARDA
Continue
Displaying 121 - 130 of 189

Sign up for email alerts

To receive news as it is released, please sign up.

@PureTechH